ImmunityBio, Inc.IBRXNASDAQ
LOADING
|||
EV to Sales: Discounted Valuation
Trending lower, below historical average, structural decline.
Left:
||||
Enterprise value to sales ratio
Latest
145.53
↓ 99% below average
Average (9y)
16657.69
Historical baseline
Range
High:42714.87
Low:145.53
CAGR
-43.1%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | 145.53 | -97.0% |
| 2023 | 4846.66 | -56.0% |
| 2022 | 11027.60 | +263.8% |
| 2021 | 3031.16 | -65.7% |
| 2020 | 8840.35 | -73.8% |
| 2019 | 33757.90 | +332.2% |
| 2018 | 7811.52 | -74.9% |
| 2017 | 31175.41 | -27.0% |
| 2016 | 42714.87 | +83.9% |
| 2015 | 23225.93 | - |